NWSF Research Grant Program supports sarcoma investigators with funding for discovery, translational research, precision medicine, and survivorship studies to accelerate progress in sarcoma research.
Funder: Northwest Sarcoma Foundation
Due Dates: October 15, 2026, at 5 p.m. Pacific Time (Full application) | December 15, 2026 (Decision notification) | January 1, 2027 (Award activation) | August 15, 2027 (Next annual application opening)
Funding Amounts: Up to $10,000 for one year (2027 awards)
Summary: Supports sarcoma-focused research spanning discovery, translational research, precision medicine, survivorship, quality of life, and supportive care.
Key Information: Research must be conducted at an academic, medical, or research institution, with no budgetary overlap with other funded projects.
The Northwest Sarcoma Foundation’s Research Grant Program supports investigators studying sarcoma through an annual funding cycle. Projects must align with the Foundation’s mission and have direct applicability and relevance to sarcoma. Research may address sarcoma broadly across subtypes or focus on a single histology, and may involve basic, clinical, translational, or epidemiological work.
The Foundation funds new discovery research, translational research, precision medicine, survivorship and quality of life, and supportive care. Its research strategy directs support toward promising sarcoma-focused investigators to accelerate progress in a disease area where rarity and complexity limit treatment options and research is often underfunded. Applicants should explain how Foundation support will advance their research, including future directions.